Supraglottic Airway Device

2

Review clinical trials related to Supraglottic Airway Device. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

An in Vivo CT Imaging Study of GMA-Tulip, I-gel, and LMA Supreme (GLAM-II)

Laryngeal masks are core devices for supraglottic airway management, and the accuracy of their anatomical position directly impacts ventilation safety and the incidence of complications. Despite their wide clinical application, gaps remain in understanding their in vivo anatomical characteristics. This study aims to evaluate the in vivo anatomical features (e.g., insertion depth, anatomical alignment, tissue compression) of three laryngeal masks (LMA Supreme, I-gel, GMA-Tulip) using CT scanning in anesthetized patients undergoing CT interventional therapy, providing anatomical evidence for optimized laryngeal mask selection and complication prevention.

Participants needed: 9
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Zhejiang Cancer HospitalUpdated: Nov 25, 2025Locations: 2
Eligibility criteria

Aged 18-75 years, scheduled for CT interventional therapy; [+3]

Presence of head/neck or airway anatomical abnormalities (e.g., laryngeal cartil... [+1]

Status: Not yet recruiting

Optimizing Third-Generation Video Laryngeal Mask Position: SaCoVLM™ vs. Fiberoptic Bronchoscope

This study aims to compare the effectiveness of SaCoVLM™ in artificial airway ventilation during general anesthesia, focusing on the correlation between native video camera imaging and fiberoptic endoscopy. Primary outcomes include the analysis of imaging correlation, while secondary outcomes assess initial placement success rates, difficulty, blood clot adherence, vital sign changes, and postoperative complications.

Participants needed: 40
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Kaohsiung Medical University Chung-Ho Memorial HospitalUpdated: Dec 27, 2024Locations: 1
Eligibility criteria

ASA classification I~III, age 18~65 y/o, BMI 18~30kg/m2, elective surgery, surge...

Smoking, betel nuts use, any known anatomical variation or disease of facial or...